Human microglia differentially respond to β‐amyloid, tau, and combined Alzheimer's disease pathologies in vivo
Year: 2025
Type: article
Abstract: INTRODUCTION: Recent studies have identified important species-dependent differences in the response of microglia to β-amyloid (Aβ) pathology. Yet, whether human microglia also interact differently with the pathognomonic combination of amyloid and tau pathologies that occur in Alzheimer's disease (AD) remains unclear. METHODS: We generated a xenotolerant mouse model of AD that develops both plaque and tangle pathologies, transplanted stem cell-derived microglial progenitors and examined the interactions between human microglia and AD pathologies with scRNA sequencing, immunohistochemistry, and in vitro modeling. RESULTS: The combined amyloid and tau pathologies induced robust type-I interferon and proinflammatory cytokine responses, as well as an increased adoption of a distinct "rod" morphology in human microglia. The rod morphology could be induced with type-I interferon treatment in vitro. DISCUSSION: We provide new insights into human microglial responses to combined AD pathologies and a novel platform to investigate and manipulate human microglia in vivo. HIGHLIGHTS: Amyloid pathology promotes the rapid development of neurofibrillary tangles and neuronal loss in a novel chimeric model of AD. Combined Alzheimer's disease pathologies lead to an expansion of disease-associated microglia (DAM) and exacerbate Interferon-responsive and cytokine/chemokine-enriched states in xenotransplanted human microglia. The combination of amyloid and tau promotes the development of a distinctive rod microglial phenotype that closely correlates with tau pathology and neurodegeneration. Rod morphology and transcriptional changes can be modeled in vitro by treatment of induced pluripotent stem cells (iPSC) -microglia with type-I interferons.
Source: Alzheimer s & Dementia
DOI: 10.1002/alz.70930
Authors: Morgan A. Coburn, Ghazaleh Eskandari‐Sedighi, Jonathan Hasselmann, Whitney England, Sepideh Kiani Shabestari, Kimiya Mansour, Amanda McQuade, Michael Armen Mgerian, Jean Paul Chadarevian, Christina Tu, Jorge Silva, Jaclyn Beck, Zahara Keulen, Robert C. Spitale, Hayk Davtyan, Mathew Blurton‐Jones
Institution: University of California, Irvine
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Keywords: human microglia, Alzheimer's disease
Open Access status: hybrid
Estimated APC paid: $4,200
Funders: Alzheimer's Association, Larry L. Hillblom Foundation, BrightFocus Foundation, Cure Alzheimer's Fund, Alzheimer Society, National Institutes of Health, National Institute on Aging, National Institute on Drug Abuse, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Center for Research Resources
Awards: G1281022434, G1464309150, Application of novel, stem-cell based approaches to study the mechanism of protective microglial response in Alzheimer’s Disease, G1922515186, High-Throughput DNA Sequencer, A novel platform for the investigation of human microglia, Examining the role of adaptive immunity in Alzheimer's Disease pathogenesis, High Throughput DNA Sequencer, G6143810018, G7146800030, Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease, PacBio RS Single Molecule, Real-Time (SMRT) DNA Sequencer, G9000260543, Cancer Center Support Grant, Training in the Neurobiology of Aging and Alzheimers Disease, Training in Translational ADRD Neuroscience (TITAN), Biology and pathobiology of apoE in aging and Alzheimer's disease, Training Program in Stem Cell Translational Medicine for Neurological Disorders, Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microglia
OpenAlex ID: W4416624751
